Home Your basket
• Temporomandibular dysfunc...
   Price 10.50 €
• How to predict post thyro...
   Price 12.00 €
• Synovial sarcoma of the h...
   Price 5.50 €
• Iatrogenic scarring of th...
   Price 12.00 €
• A case of laryngeal sialo...
   Price 10.50 €
• The place of anti-viral i...
   Price 10.50 €
• From intelligibility to c...
   Price 10.50 €
• Recent advances in surger...
   Price 5.50 €
• Cutaneous horn of the pin...
   Price 5.50 €
• An original case of laryn...
   Price 8.50 €
• Singular neurectomy for r...
   Price 12.00 €
• Idiopathic sudden deafnes...
   Price 10.50 €
• Fronto-ethmoidal fibrous ...
   Price 8.50 €
• Quality of life evaluatio...
   Price 10.50 €
• Otomycosis...
   Price 10.50 €
• A study of peristomal rec...
   Price 5.50 €
• Are we sectioning the coc...
   Price 10.50 €
• Laryngeal neuroendocrin c...
   Price 5.50 €
• Different methods in iden...
   Price 14.00 €
• Conference : Medicine of ...
   Price 5.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Abscess tonsillectomy for...
   Price 10.50 €
• Laryngeal sarcoidosis: Ca...
   Price 5.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Navigation in head and ne...
   Price 10.50 €
• Carcinogenesis of the eth...
   Price 10.50 €
• Vertigo: progress and pra...
   Price 8.50 €
• The subjective visual ver...
   Price 10.50 €
• Endoscopic anatomy of the...
   Price 10.50 €
• Sinonasal malignant schwa...
   Price 5.50 €
• Delayed labyrinthine fist...
   Price 10.50 €
• Speech intelligibility in...
   Price 10.50 €
• Cervical and pharyngeal i...
   Price 5.50 €
• Cochlear implantation in ...
   Price 5.50 €
• Exophthalmos arising from...
   Price 10.50 €
• Chondrosarcoma of the hyo...
   Price 12.50 €
• Endoscopic ligation of th...
   Price 12.00 €
• Use of instrumental vocal...
   Price 10.50 €
• Asymptomatic findings on ...
   Price 14.00 €
• Failure rate and revision...
   Price 10.50 €

Total Order 372.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 1 - 2016 o

RHINOLOGY

Efficacy of nasal irrigation with 2.2% hypertonic seawater in the treatment of chronic rhinosinusitis in adults


Authors : Strnad P, Skoupá J, HornÍk P, Cimrová H, Cerná V. (Prague)

Ref. : Rev Laryngol Otol Rhinol. 2016;137,1:3-10.

Article published in english
Downloadable PDF document english



Summary : Objective: To evaluate the efficacy and the tolerance of nasal irrigation with 2.2% hypertonic seawater in the treatment of chronic rhinosinusitis (CRS) in adults either used as mono­therapy, or in combination with intranasal corticosteroids. Method: In this prospective, open-label, multicenter controlled trial, 238 patients diagnosed with CRS were randomly assigned to three groups: group 1 with intranasal corticosteroids (steroid), group 2 with nasal irrigation with hypertonic seawater (seawater) and group 3 with a treatment combining intranasal corticosteroids at lower dose and seawater (steroid+seawater). Nasal index score (NIS), patient health status, intranasal corticosteroids intake, tolerance were assessed at baseline, week 2 and 6, and satisfaction at week 6. Results: NIS was significantly improved in group 2 (seawater) and group 3 (steroid+seawater) at week 2 (p< 0.001 in both groups) and week 6 (p< 0.0001 in both groups) compared to group 1 (steroid), along with a significant decrease of intranasal corticosteroids (p < 0.0001). Patient health status improved in group 2 and group 3 at week 2 (p= 0.1040 and p< 0.001 respectively) compa­red to control (steroid), and this improvement was significantly greater in both groups at week 6 compared to steroid group (p< 0.0001). Conclusion: Hypertonic nasal irrigation is an effective treatment for CRS in adults. It significantly improved nasal symptoms and allowed a signi­fi­cant decrease of intranasal corticosteroids use while improving patient health status. Nasal irrigation with 2.2% hypertonic seawater could therefore be considered as first-line treatment for CRS, either as monotherapy or in combination with lower dosage of intranasal corticosteroids.

Price : 15.00 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE